Germany· DE-A57-1a7cd1c883b84aa7
Nemased
A medicinal product containing veratrum album dil d3, passiflora incarnata d3, packera aurea d4, castoreum d3, avena sativa dil. d3, phosphorus dil. d6, registered in Germany by Nestmann Pharma Gmbh.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Veratrum Album Dil D3, Passiflora Incarnata D3, Packera Aurea D4, Castoreum D3, Avena Sativa Dil. D3, Phosphorus Dil. D6
- Manufacturer
- Nestmann Pharma Gmbh
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e96bb459-ca9c-4822-897c-20e5b35d233d GET /v1/drugs/e96bb459-ca9c-4822-897c-20e5b35d233d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Veratrum Album Dil D3, Passiflora Incarnata D3, Packera Aurea D4, Castoreum D3, Avena Sativa Dil. D3, Phosphorus Dil. D6",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about veratrum album dil d3, passiflora incarnata d3, packera aurea d4, castoreum d3, avena sativa dil. d3, phosphorus dil. d6.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.